Search Results

Sysmex® XE-5000 is an automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories. The XE-5000 classifies and enumerates the same parameters as the XE-2100 using whole blood as described below, cord blood for HPC and has a body fluid mode for body fluids. The Body Fluid mode analyzes WBC-BF, RBC-BF, MN%#, PMN%# and TC-BF in body fluids (cerebrospinal fluids (CSF), serous fluids, and synovial fluids with EDTA, as needed).

The Sysmex® XE-5000 is part of the XE-Series instrument line. It is a multi-parameter hematology analyzer intended to perform tests in anti-coagulated blood and body fluids. The instrument consists of three principal units: (1) Main Unit which aspirates, dilutes, mixes and analyzes blood and body fluid samples; (2) Auto Sampler Unit supplies samples to the Main Unit automatically; (3) IPU (Information Processing Unit) which processes data from the Main Unit and provides the operator interface with the system. The XE-5000 is equipped with a Sampler that provides continuous automated sampling for up to 100 tubes. The XE-5000 performs analyses using the following methods: RF/DC Detection Method, Sheath Flow DC Detection Method, and Flow Cytometry Methods using a Semiconductor Laser. Particle characterization and identification is based on detection of forward scatter, fluorescence and adaptive cluster analysis. Using the same reagents as the XE-2100, the XE-5000 automatically classifies cells from blood and body fluids and carries out all processes automatically from aspiration of the sample to outputting the results. The body fluid analysis mode of the XE-5000 uses the 4DIFF scattergram & the RBC distribution obtained from a specialized analysis sequence to calculate & display the WBC (WBC-BF) counts, mononuclear cell (MN) / polymorphonuclear cell (PMN) counts & percentages, TC-BF (Total Count) & RBC (RBC-BF) counts found in the body fluid. Analysis results and graphics are displayed on the IPU screen. They can be printed on any of the available printers or transmitted to a Host computer.

Here's a breakdown of the acceptance criteria and study information for the Sysmex XE-5000, based on the provided text:

Acceptance Criteria and Device Performance

The document states that the performance of the XE-5000 whole blood mode is the same as the XE-2100 with additional masters. For the Body Fluid mode, which has additional parameters (WBC-BF, RBC-BF, MN%/#, PMN%/#, TC-BF#), the claim is "excellent correlation" to the XE-2100 Body Fluid. The acceptance criteria themselves are not explicitly listed as specific numerical thresholds, but rather implied by "manufacturer's specification" and "excellent correlation".

Note: The document only mentions "manufacturer's specification" without providing the specific numerical values for these specifications (e.g., specific accuracy percentages, CVs for reproducibility, etc.). It claims "excellent correlation" to the predicate device, the Sysmex XE-2100.

Study Information

1. Sample size used for the test set and the data provenance:

   • Sample Size: Not explicitly stated as a number of samples. The document mentions "Data consisting of carryover, linearity, accuracy and reproducibility was collected to show performance to the manufacturer's specification for the Body Fluid mode."
   • Data Provenance: Not explicitly stated (e.g., country of origin, specific institutions). The text also doesn't specify if the study was retrospective or prospective.

2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

   • Not applicable/Not mentioned. The study involves comparing the new device against a predicate device (Sysmex XE-2100) and against manufacturer's specifications, rather than using expert-established ground truth for each case. The ground truth for the predicate device would have been established previously.

3. Adjudication method for the test set:

   • Not applicable/Not mentioned. The study appears to be a direct comparison of instrument measurements rather than an assessment requiring multiple human readers and adjudication.

4. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

   • No. This is an automated hematology analyzer, not an AI-assisted diagnostic tool for human readers in the traditional sense of an MRMC study.

5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

   • Yes, the performance data presented is for the standalone device, the Sysmex XE-5000, in comparison to another standalone device (Sysmex XE-2100). The device is an "automated hematology analyzer," implying standalone operation.

6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

   • For the body fluid mode, the ground truth for comparison appears to be the performance of the Sysmex XE-2100 Body Fluid (the predicate device), as well as the manufacturer's internal specifications for parameters like accuracy, linearity, and reproducibility.

7. The sample size for the training set:

   • Not applicable/Not mentioned. The document describes a new iteration of an existing automated analyzer, not a machine learning model that requires a distinct training set. The "training" in this context would likely refer to the internal validation and development data used during the instrument's design process, which is not detailed here.

8. How the ground truth for the training set was established:

   • Not applicable/Not mentioned, as there is no specific "training set" described for a machine learning algorithm. If considered from an instrument development perspective, the ground truth for optimizing the instrument's performance would rely on established laboratory methods and reference ranges.

Ask a specific question about this device